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Summsry 
We studied the coupling of the TCK/CD3 complex to a T  cell effector function, namely Fas- 
based T cell-mediated cytotoxicity. Encounter or re-encounter with antigen was mimicked by 
treating 5 d mixed lymphocyte culture cells or T cell hybridomas with anti-CD3 antibody. This 
TCR/CD3 engagement induced swift expression of Fas-based cytotoxicity in these cells. Induction 
of Fas-based  cytotoxicity was  Ca2+-dependent,  while its  execution was not;  induction was 
sensitive to macromolecular synthesis inhibitors, in line with a demonstrable increase of the Fas 
ligand (Fas-L) message. We also used T cell hybridomas transfected with various constructs to 
dissect the involvement of distinct components of the TCR/CD3  complex. The cytoplasmic 
domain of the CD3 ~" chain was able to transduce by itself a signal leading to Fas-L expression, 
unless there were mutations in its activation receptor homology sequence 1 (ARH-1) motifs. 
On the one hand, these findings are relevant to signal transduction pathways coupled to the 
TCR/CD3, and on the other hand, to the involvement of Fas-based T cell-mediated cytotoxicity 
in various physiological and possibly pathophysiological situations. 
T 
wo molecular mechanisms of T cell-mediated cytotox- 
icity have recently been defined. Gene knock-out pro- 
cedures that  produced perforin-deficient (1)  or  granzyme 
B-deficient (2) mice led to the demonstration of a granule 
exocytosis-perforin-granzyme  B pathway. A Fas pathway had 
been independently defined through a requirement for Fas 
at the target cell surface (3, 4). In short-term T cell-mediated 
cytotoxicity assays both the perforin-based and the Fas-based 
mechanisms, and no third mechanism, could be detected under 
all tested circumstances (5). The Fas-based mechanism con- 
tributes in particular to antigen-specific T cell-mediated cy- 
totoxicity (3). Because the Fas ligand (Fas-L) (6) is required 
at the effector cell surface to ensure Fas-based  cytotoxicity 
and because T cells do not normally kill via Fas unless there 
is specific antigen recognition, we assumed that TCK/CD3 
engagement induced the functional availability of this Fas-L (3). 
The TCR/CD3  complex includes at  the cell surface a 
module responsible for antigen recognition (TCK) and at least 
four distinct associated polypeptides (CD33,, CD3/~, CD3~, 
and CD3~') that ensure assembly of the complex as well as 
signal transduction. In the cytoplasmic domain of the CD3 
components, an 18 amino acid motif  based on a tandem YXXL 
stretch, the activation receptor homology sequence 1 (ARH-1), 
carries sufficient structural information to activate both early 
and late signaling events (reviewed in 7). Pioneering experi- 
ments  demonstrated that  the CD3~" ARH-1  motif could 
trigger cytotoxicity but the cytotoxicity mechanism(s) in- 
volved were not known at the time (8). 
The findings reported here show that TCR/CD3  stimu- 
lation of MLC or hybridoma T cells was able to induce Fas- 
based cytotoxicity,  as  reported recently elsewhere (9-11). 
Moreover, in T cell hybridomas, induction could be obtained 
through the cytoplasmic domain of the CD3  ~" chain and 
it required the integrity of its ARH-1 motifs. The induction 
of Fas-based  cytotoxicity was  dependent  on  extracellular 
Ca  2+, while its execution was not,  and induction required 
macromolecular synthesis. Depending on the activated T cells, 
the required Ca  2+-dependent step was completed within 1-3 
h and an increased expression of the Fas-L message could be 
demonstrated within the same time frame. Thus, signaling 
through the TCK/CD3 pathway led to rapid expression of 
the Fas-L, accounting at least in part for very swift induc- 
tion of Fas-based T cell-mediated cytotoxicity upon antigen- 
specific restimulation. 
Materials  and Methods 
Effector T  Cells.  For MLCs, spleen cells were obtained from 
2-3-month-old C57B1/6 (H-2b, b) or BALB/c (H-2d, d) mice and 
processed as indicated (12). On average, 50% of the initial input 
of responder cells were recovered on day 5. PC60-d11S (d11S) was 
a subclone of the dl0S clone, shown to exert Fas-based  cytotoxicity 
exclusively (3) and previously derived by serial subcloning (3, 4) 
from the PC60 mouse x  rat cytotoxic T hybridoma cell (13). The 
routine T cell hybridomas L16.24 and T16.19 expressed a CD25/~" 
chimeric molecule made of the complete human CD25 ecto- and 
transmembrane domains fused to the complete mouse CD3 ~" cyto- 
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chimeric molecule in which the Y residues at positions Y72, Yl11, 
and Y142 of the CD3~'cytoplasmic segment, i.e., the first Y residues 
of each of the three CD3 ~" ARH-1 motifs, had been converted into 
F residues  (14). Flow cytometric analysis of the hybridomas was 
performed as indicated (15). Effector T cells were tested for cyto- 
toxicity either directly or after a preincubation period. 
Preincubation.  Effector T cells (5  x  106) were preincubated in 
2.5  ml of culture medium per well of 6-well plates (Falcon Lab- 
ware, Oxnard, CA), either as a control in medium alone or in the 
presence of PI, which is a mixture of PMA (no. P-8139, 2.5 ng/mI; 
Sigma Chemical  Co.)  and  ionomycin  (no.  407952,  0.5  /zg/ml; 
Calbiochem-Behring Corp., San Diego, CA),  or after overnight 
coating of the well with purified antibodies.  Coating was performed 
at 4~  with 5 #g of antibody in 0.5 ml of PBS per well with use 
of either the 145-2Cll  hamster anti-mouse CD3e antibody (16) 
or  the  B1.49.9  mouse  anti-human  CD25  antibody  (0119; Im- 
munotech, Marseille,  France). The duration of preincubation on 
antibody-coated plastic was 1 h  for MLC cells or 3  h  for T  cell 
hybridomas. In some experiments, preincubation was done in the 
presence of cycloheximide (10 #g/ml; Sigma Chemical Co.; in this 
series of experiments, there was only one wash ofeffector cells after 
preincubation, which probably led to carry-over of cycloheximide 
to the cytotoxicity test, which would account for the absence of 
reversal of the cycloheximide block seen in Fig.  1) or in the pres- 
ence of actinomycin D (10 #g/ml; Sigma Chemical Co.) or I mM 
EGTA plus  1.5  mM Mg 2§  to chelate most of the extracellular 
Ca  2+  in the presence of an excess of Mg  2+. 
Target Cells.  Target cells used were either the DBA/2,  H-2d 
T cell lymphoma L1210 cells, expressing low amounts of Fas (3), 
or derivatives thereof. L1210-3 was obtained by repeated selection 
of L1210 with Fas-based d11S killer cells. 2  x  106 d11S cells were 
preactivated for 3 h by PMA (2.5 ng/ml) and ionomycin (0.5 #g/ml), 
incubated for 30 min in the presence of mitomycin C (75/~g/ml), 
and rinsed 3 x  in medium. These cells were mixed with 2  x  10  s 
L1210 cells in 1 ml of medium, centrifuged for i min at 1,200 rpm, 
and incubated for 4 h.  This cell mixture was cultured for 72 h 
and 5  x  105 of the remaining cells (most of which were L1210 
cells by morphology) were incubated for another 4 h  with 2  x 
106 d11S cells treated as described above. After 3 days in culture, 
the cells were cloned by limiting dilution. Cells from the L1210-3 
clone had less residual sensitivity to Fas-based  cytotoxicity than 
the L1210  cells  used  initially  (3) but  remained sensitive to  the 
perforin-based mechanism (data not shown).  The previously de- 
scribed L1210-Fas clone was obtained by transfection of L1210 with 
a Fas cDNA (3). 
SlCr-release Cytotoxicity Test.  The cytotoxicity tests were per- 
formed essentially as described previously (12). In each V-shaped 
well of 96-well microtiter plates we placed, in a total volume of 
200/A, 104 SlCr-labeled target cells, effector cells (preincubated or 
not) to the indicated ratios, and in some cases either PI or Con A 
(no. C-7, 10 #g/ml, final dilution; Sigma Chemical Co.), or a mix- 
ture of EGTA and Mg  2+ as above. In some experiments, effector 
cells were incubated in microplate wells for 30 rain with the soluble 
chimeric  molecule  Fas-Fc  (6),  then  target  cells  were  added. 
Microplates were centrifuged for I min at 1,500 rpm and incubated 
for 4 h  at 37~ 
Northern Blot Analysis.  Hybridoma cells were preincubated for 
3 h with medium, immobilized anti-CD3 mAb, immobilized anti- 
CD25 mAb, or PI.MLC cells were preincubated similarly but for 
only 1 h. Cells were harvested in EDTA and total RNA was ex- 
tracted using TRIzol reagent (GIBCO BRL, Gaithersburg, MD) 
according to the manufacturer's protocol. Total KNAs (20/zg/lane) 
were then run on 1.2% agarose-formaldehyde gels and transferred 
to Hybond-N membranes (Amersham Corp., Arlington Heights, 
IL). Membranes were prehybridized  and hybridized in Church buffer 
(NaPi 0.5 M, pH 7.2; SDS 7%; EDTA I raM) with use of a full- 
length Fas-L cDNA fragment (6) as a probe. 
Results 
TCR/CD3  Induction of Fas-based Cytotoxicity  in Activated 
T  Cell Populations.  We tested whether engagement of the 
TCR/CD3  complex induces Fas-based cytotoxicity in MLC 
cells. Following the techniques used in previous reports (3, 
5,  12), we used L1210-Fas target cells (sensitive to both Fas- 
based  and  perforin-based  mechanisms)  in  the  presence  of 
EGTA-Mg  2§  (which prevents perforin-based lysis) to assess 
Fas-based cytotoxicity exclusively, d  anti-b MLC cells were 
preincubated for 1 h  either with PI as a positive control or 
with anti-CD3 antibodies, then tested for cytotoxicity in the 
presence of EGTA-Mg 2+ .  As expected,  little  (Fig.  1  b)  or 
no (Fig. 1 d) cytotoxicity was detected on control L1210 target 
cells because L1210 cells are poorly sensitive to Fas-based cy- 
totoxicity and EGTA-Mg  2+  does not  allow perforin-based 
cytotoxicity. Fas-based cytotoxicity was detected on L1210- 
Fas target cells (Fig.  1, a and c).  Further evidence for a Fas- 
based mechanism, in addition to preferential lysis of Fas-bearing 
target cells and to Ca  2 +-independent  lysis, was provided by 
the inhibition by soluble Fas-Fc molecules (6) of cytotoxicity 
so 
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Figure  I.  TCR/CD3 induction 
of Fas-based T cell-mediated cyto- 
toxicity in MLC cells, its Ca 2+ de- 
pendence and requirement for pro- 
tein synthesis, d anti-b MLC cells 
were preincubated for  1 h either 
with PI (a and b) or on a plastic sur- 
face coated with  anti-CD3  anti- 
bodies (c and d) in the presence of 
medium (O) EGTA-Mg  2  + (A), or 
cycloheximide  (I-q). The subsequent 
4-h cytotoxicity test was performed 
on L1210-Fas or on L1210 target 
cells in  the  presence of EGTA- 
Mg  2+ .  The cytotoxicity of these 
d anti-b cells preincubated without PI or anti-CD3  antibodies (at a ratio of 30:1) was 17% for L1210-Fas and 12% for L1210 target cells. Results 
are given as percent experimental slCr release minus percent release from target cells alone, which was 9-12%. 
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Figure 2.  Cell  surface  phenotype 
ofL16.24, L17.2, and T16.19 T cell 
hybridomas. These were assayed 
for the surface expression of CD3 
(  ....  ) and CD25 (  ) chimeric 
molecules using indirect  immuno- 
fluorescence and flow cytometry. 
Anti-CD3 and anti-CD25 antibodies 
were as indicated  in Materials and 
Methods, and the control  antibody 
(....) was the anti-CDSot  H58.55.3 
antibody. 
induced by PI or by anti-CD3 antibodies (data not shown). 
Thus, anti-CD3 antibodies engaging the TCR/CD3 com- 
plex of MHC cells could trigger Fas-based cytotoxicity. 
In addition, induction of Fas-based cytotoxicity  could not 
take place if incubation with anti-CD3 antibodies was done 
in the presence of EGTA-Mg  ~  § (Fig. I c). Thus, TCR/CD3- 
mediated induction,  as  opposed  to  execution  (3,  17), of 
Fas-based  T  cell-mediated cytotoxicity in activated T  cell 
populations included a Ca2+-dependent stage(s).  Also, Fas- 
based  cytotoxicity was not induced if preincubation with 
anti-CD3 antibodies was done in the presence of  cycloheximide 
(Fig. I c) or actinomycin D (data not shown), indicating that 
the synthesis of at least one macromolecular species was re- 
quired in the effector cell for induction of Fas-based cytotoxic 
activity. 
TCR/CD3 Induction of Fas-based Cytotoxicity in T Cell Hy- 
bridomas.  L16.24  and L17.2  expressed  similar amounts of 
surface CD3, while T16.19  expressed  far less surface CD3 
(Fig. 2). Accordingly, while cytotoxicity was induced by PI 
in all three hybridomas, it was induced by anti-CD3e anti- 
bodies in L16.24 and L17.2 but not in T16.19 (Fig. 3, a-c). 
All three hybridomas expressed similar amounts of cell sur- 
face human CD25 (Fig. 2). CD25 tagged a CD3~"  cytoplasmic 
domain, which, however, was wild-type for L16.24 and T16.19 
and mutated on the first tyrosine residues  of each ARH-1 
motif for L17.2. Indeed anti-CD25 antibodies induced cyto- 
toxicity in L16.24 and T16.19 but not in L17.2 (Fig. 3, a-c). 
These combinations led to a contrasted effect of anti-CD3 
and anti-CD25 antibodies on T16.19  and L17.2  (Fig.  3,  b 
and c). Under the various induction conditions used, these 
three hybridomas significantly lysed L1210-Fas but not L1210-3 
cells (Fig. 3, d-f), indicating that the cytotoxicity  thus gener- 
ated was Fas based. These results show that in these hybrid- 
omas Fas-based cytotoxicity could be induced via PI, or via 
the TCR/CD3 complex, or via the CD3 ~" chain in isola- 
tion. Induction through the latter required the tyrosine motifs 
previously implicated in signal transduction. 
The cytotoxicity by L16.24  hybridoma cells after induc- 
tion by PI, anti-CD3, or anti-CD25 antibodies was increased 
if EGTA-Mg  2+ was added during the cytotoxicity test (Fig. 
4,  a  and b).  In marked contrast,  it was absent if EGTA- 
Mg  2+ was added during induction (Fig. 4, a and c). In this 
case induction was once again almost completely blocked when 
cycloheximide or actinomycin D was present (data not shown). 
Again, this cytotoxicity  was essentially (if not only) Fas based 
because it was much more marked on L1210-Fas than on L1210 
(Fig. 4, d-f).  These results show that for these hybridoma 
cells as well, execution of Fas-based cytotoxicity was Ca  2+ 
independent but its induction required extracellular Ca2+; 
from another point of view, it also required macromolecular 
synthesis. 
The TCR/CD3 Complex Signals Increased Expression of the 
Fas-L.  Fas-L transcripts, which were not or were only barely 
detectable in nonactivated L16.24,  L17.2, and T16.19 T cell 
hybridomas (Fig.  5), were readily detectable in all of these 
hybridomas upon a 3-h incubation with PI (Fig. 5 and data 
not shown). Their appearance was induced by anti-CD3 an- 
tibodies in L16.24 and L17.2 much more than in T16.19, and 
by anti-CD25 antibodies in L16.24  and T16.19  but not in 
L17.2. Thus, appearance of Fas-L transcripts (Fig. 5) correlated 
with appearance of Fas-based cytotoxicity (Fig. 3), and they 
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Figure 3.  Induction  of Fas-based cytotoxicity  in T cell hybridomas 
through CD3 or its isolated ~" chain. The indicated  hybridomas  were in- 
cubated for 1 h either in medium alone (O), or with PI (A), or on a 
plastic surface  coated  with anti-CD3 (O) or anti-CD25 (.) antibodies. 
The subsequent 4-h cytotoxicity  test was performed  on L1210-Fas or on 
L1210-3 target cells. Results are given as percent experimental stCr re- 
lease minus percent release from target cells alone, which was 5-7%. 
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Figure 4.  Ca  2+  dependence  of 
TCR/CD3 induction (but not of 
the execution) of Fas-based cytotox- 
icity in a T  cell hybridoma.  The 
L16.24 hybridoma was preincubated 
for I h either in medium alone (O), 
or with PI (&), or on a plastic sur- 
face coated with anti-CD3 (0) or 
anti-CD25  (m)  antibodies￿9 This 
preincubation was in the presence  of 
EGTA-Mg  2+ (c andJ) or in its ab- 
sence. The subsequent 4-h cytotox- 
icity test was performed on L1210- 
Fas or on L1210 target cells, in the 
presence of EGTA-Mg  a+  (b and e) 
or in its absence￿9  Results are  given 
as percent experimental SlCr release 
minus percent  release from target 
cells alone, which was 10-16%. 
could be similarly obtained through engagement of the whole 
TCR/CD3  complex or of an intact CD3  ~" chain. 
Discussion 
Acquisition of the ability to exert Fas-based  cytotoxicity 
is most probably directly linked to expression of the Fas-L 
(6), although some contribution of other molecules, perhaps 
also inducible, cannot be ruled out. Expression of the Fas-L 
may be due to increased stability of  preexisting message and/or 
to increased transcription. The latter would be consistent with 
the observed block of induction of Fas-based cytotoxicity in 
MLC cells and in L16.24  hybridoma cells by cycloheximide 
Figure  5.  Expression  of Fas-L mRNA in TCR/CD3-activated T cell 
hybridomas.  These were preincubated  for 3 h with medium alone, im- 
mobilized anti-CD3 mAb, immobilized anti-CD25 mAb, or PI. Total RNA 
was then extracted, and Fas-L mRNA expression was assessed  by Northern 
blot analysis as described in Materials and Methods.  Ethidium bromide 
staining  showed that similar amounts of RNA had been loaded in each 
well. The "~2-kb size of the Fas-L transcript  was consistent with previous 
results  (6). 
or actinomycin D.  In a very similar manner, induction by 
PI of dl0S cytotoxicity could be blocked by cycloheximide 
and actinomycin D (17). Execution of Fas-based cytotoxicity 
did not require macromolecular synthesis (17). 
Expression of the Fas-L must be tightly controlled because 
the presence of Fas on a number of tissues  within and out- 
side the immune system would make uncontrolled expres- 
sion quite dangerous (18). The present work shows that the 
Fas-L, which is not constitutively expressed even on activated 
lymphocytes, can be swiftly induced on them by restimula- 
tion  of the  TCR/CD3  complex.  Activated  lymphocytes 
resulting from a 5-d MLC do not express,  or no longer ex- 
press,  detectable levels of the Fas-L  (data not shown), and 
correlatively do  not  spontaneously lyse via  the  Fas-based 
pathway unless they are reactivated through their TCR/CD3. 
This may be obtained with anti-TCR/CD3 antibodies or in 
a cytotoxicity test upon engagement of the TCR with specific 
aUoantigen-bearing  target  cells.  A  1-h  triggering  of the 
TCR/CD3,  which is enough to induce Fas-based  cytotox- 
icity in 5-d MLC cells, is not enough to induce it in normal 
splenic T  cells (data not shown); these cells require longer 
incubations with anti-TCR antibodies (19). Thus, a long or 
repeated schedule of activation is required to generate Fas- 
based cytotoxic activity. This may mimic either repeated or 
prolonged activation by antigen in vivo. In particular,  chronic 
T lymphocyte activation states (such as those seen in autoim- 
mune diseases, or perhaps in some viral diseases) are likely 
to induce Fas-based cytotoxicity and its eventual physiopatho- 
logical consequences. The latter may have an effect on the 
immune system itself,  since Fas is involved in its regulation 
(as shown by the immune dysfunctions in Ipr mice; refer- 
ences 20-22), perhaps through Fas-based cytotoxicity (12). 
Once expression of the Fas-L is induced, even within the 
short duration of a 4-h cytotoxicity test, by specific antigen 
recognition via the TCR, it would lead to Fas-based cytol- 
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irrelevant,  Fas-bearing  target  Cells. In other words, induc- 
tion of Fas-based cytotoxicity is antigen-specific,  while its 
execution may not be. This may lead to bystander cell lysis 
as a function of Fas expression by the bystander cells. Differ- 
ences in Fas expression may account for some of the discrepan- 
cies reported in the literature as to the extent of bystander lysis. 
Although the execution of Fas-based cytotoxicity is Ca  2+ 
independent, its induction (for instance, within the cytotox- 
icity test itself following antigen-recognition)  requires ex- 
traceUular  Ca  2  + (Figs.  1 and 4).  Also,  addition  of EGTA- 
Mg  2+ to known Fas-based cytotoxicity systems tends to in- 
crease  SlCr  release,  as  shown with  preinduced  L16.24 hy- 
bridoma cells (Fig.  4), for reasons that  are not clear to us. 
Thus,  addition  of EGTA-Mg  2+  may tend to both increase 
and decrease Fas-based cytotoxicity to an unpredictable final 
level.  Clearly, while the existence of EGTA-Mg 2§ 
cytotoxicity is a good indication of a Fas-based mechanism, 
the  extent  of this  EGTA-Mg2+-resistant  cytotoxicity pro- 
vides no reliable estimate of the extent of Fas-based cytotoxicity. 
TCR/CD3 engagement leads to the sequential activation 
of protein tyrosine kinase (PTK) src family members,  such 
as p59fyn and p561ck,  to the tyrosine phosphorylation  of 
ARH-1 tandem tyrosines, and to the subsequent recruitment 
and activation of tandem SH2 FIX, such as ZAP70 and p72syk 
(7). We show here that CD3~" in isolation can induce Fas- 
based T  cell cytotoxicity, provided there is integrity of the 
CD3~" ARH-1 motifs, as also found for CD3~" coupling to 
Ca  2+ mobilization and to IL-2 secretion in the same hybrid- 
omas (14). Since only the first tyrosine residues of each ARH-1 
motif were mutated in the CD25/~3YF chimeric molecule, 
these results further indicate that coupling of CD3~" to the 
Ca2+-dependent  pathway  to  Fas-L  expression  most  likely 
necessitates the recruitment of tandem SH2 PTK. d11S cells, 
which could not be activated by anti-CD3  antibodies and 
were negative by FACS  |  for expression of CD3  (data not 
shown), could be activated by PI to express the Fas-L, indi- 
cating that  induction  of Fas-L by PI can also occur in the 
absence of cell surface expression of the TCR/CD3 complex. 
Independent evidence also pointing at the implication of PTKs 
was provided by the inhibition  by the PTK inhibitors  her- 
bimycin A and genistein of the expression of Fas-L mRNA 
in cytotoxic T cell clones (11). Similarly, the requirement for 
Ca  2+  in this induction  pathway (shown here) is paralleled 
by the inhibitory effect of cyclosporin A (11), and both are 
consistent  with calcineurin  involvement.  As a whole,  our 
results for induction of Fas-L expression are consistent with 
results on the use of the classical pathway described for IL-2 
expression following engagement  of the TCR/CD3  com- 
plex (7, 23). For the Fas-L gene, differences in kinetics sug- 
gested that the machinery required for Fas-L expression preex- 
isted more abundantly or more efficiently in MLC cells than 
in T hybridoma cells, and again, more in T hybridoma cells 
than in normal unstimulated T lymphocytes. It is interesting 
that other members of the TNF family seem to follow a similar 
regulation  (23),  particularly  as  to  rapid  expression  after 
TCR/CD3  engagement  (24). 
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